Literature DB >> 26171280

AF4 and AF4N protein complexes: recruitment of P-TEFb kinase, their interactome and potential functions.

Bastian Scholz1, Eric Kowarz1, Tanja Rössler1, Khalil Ahmad2, Dieter Steinhilber2, Rolf Marschalek1.   

Abstract

AF4/AFF1 and AF5/AFF4 are the molecular backbone to assemble "super-elongation complexes" (SECs) that have two main functions: (1) control of transcriptional elongation by recruiting the positive transcription elongation factor b (P-TEFb = CyclinT1/CDK9) that is usually stored in inhibitory 7SK RNPs; (2) binding of different histone methyltransferases, like DOT1L, NSD1 and CARM1. This way, transcribed genes obtain specific histone signatures (e.g. H3K79me2/3, H3K36me2) to generate a transcriptional memory system. Here we addressed several questions: how is P-TEFb recruited into SEC, how is the AF4 interactome composed, and what is the function of the naturally occuring AF4N protein variant which exhibits only the first 360 amino acids of the AF4 full-length protein. Noteworthy, shorter protein variants are a specific feature of all AFF protein family members. Here, we demonstrate that full-length AF4 and AF4N are both catalyzing the transition of P-TEFb from 7SK RNP to their N-terminal domain. We have also mapped the protein-protein interaction network within both complexes. In addition, we have first evidence that the AF4N protein also recruits TFIIH and the tumor suppressor MEN1. This indicate that AF4N may have additional functions in transcriptional initiation and in MEN1-dependend transcriptional processes.

Entities:  

Keywords:  7SK RNP; AF4/AF4N; P-TEFb; RNA polymerase II; elongation control

Year:  2015        PMID: 26171280      PMCID: PMC4497493     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  51 in total

1.  Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.

Authors:  Y Ramanathan; S M Rajpara; S M Reza; E Lees; S Shuman; M B Mathews; T Pe'ery
Journal:  J Biol Chem       Date:  2001-01-16       Impact factor: 5.157

2.  Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.

Authors:  Emiko Urano; Yumi Kariya; Yuko Futahashi; Reiko Ichikawa; Makiko Hamatake; Hidesuke Fukazawa; Yuko Morikawa; Takeshi Yoshida; Yoshio Koyanagi; Naoki Yamamoto; Jun Komano
Journal:  FEBS Lett       Date:  2008-11-07       Impact factor: 4.124

3.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

Authors:  Nanhai He; Min Liu; Joanne Hsu; Yuhua Xue; Seemay Chou; Alma Burlingame; Nevan J Krogan; Tom Alber; Qiang Zhou
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

Review 4.  Cracking the RNA polymerase II CTD code.

Authors:  Sylvain Egloff; Shona Murphy
Journal:  Trends Genet       Date:  2008-05-03       Impact factor: 11.639

5.  HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold.

Authors:  Seemay Chou; Heather Upton; Katherine Bao; Ursula Schulze-Gahmen; Avi J Samelson; Nanhai He; Anna Nowak; Huasong Lu; Nevan J Krogan; Qiang Zhou; Tom Alber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-18       Impact factor: 11.205

6.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

7.  Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC).

Authors:  Chengqi Lin; Alexander S Garrett; Bony De Kumar; Edwin R Smith; Madelaine Gogol; Christopher Seidel; Robb Krumlauf; Ali Shilatifard
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

8.  Crystal structure of HIV-1 Tat complexed with human P-TEFb.

Authors:  Tahir H Tahirov; Nigar D Babayeva; Katayoun Varzavand; Jeffrey J Cooper; Stanley C Sedore; David H Price
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

9.  Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.

Authors:  Lisa Muniz; Sylvain Egloff; Bettina Ughy; Beáta E Jády; Tamás Kiss
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

10.  LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.

Authors:  C Ma; L M Staudt
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

View more
  8 in total

1.  Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.

Authors:  Alona Kuzmina; Simona Krasnopolsky; Ran Taube
Journal:  Transcription       Date:  2017-02-17

2.  TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.

Authors:  Hiroshi Okuda; Satoshi Takahashi; Akifumi Takaori-Kondo; Akihiko Yokoyama
Journal:  Cell Cycle       Date:  2016-08-26       Impact factor: 4.534

3.  DDX6 transfers P-TEFb kinase to the AF4/AF4N (AFF1) super elongation complex.

Authors:  Fabian Mück; Silvia Bracharz; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2016-09-15

Review 4.  Molecular processes involved in B cell acute lymphoblastic leukaemia.

Authors:  Camille Malouf; Katrin Ottersbach
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

5.  Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.

Authors:  Simona Krasnopolsky; Lital Marom; Rachel A Victor; Alona Kuzmina; Jacob C Schwartz; Koh Fujinaga; Ran Taube
Journal:  Retrovirology       Date:  2019-06-25       Impact factor: 3.768

Review 6.  Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.

Authors:  Rolf Marschalek
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

7.  Reconstitution of a functional 7SK snRNP.

Authors:  John E Brogie; David H Price
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

8.  Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.

Authors:  Antonio Agraz-Doblas; Clara Bueno; Rachael Bashford-Rogers; Anindita Roy; Pauline Schneider; Michela Bardini; Paola Ballerini; Gianni Cazzaniga; Thaidy Moreno; Carlos Revilla; Marta Gut; Maria G Valsecchi; Irene Roberts; Rob Pieters; Paola De Lorenzo; Ignacio Varela; Pablo Menendez; Ronald W Stam
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.